z-logo
open-access-imgOpen Access
18F-fluorodeoxyglucose positron emission tomography/computed tomography features in locally advanced breast cancer and their correlation with molecular subtypes
Author(s) -
Siddhant Khare,
Swaiman Singh,
Santhosh Irrinki,
Yashwant Sakaray,
Bhagwant Rai Mittal,
Amanjit Bal,
Gurpreet Singh
Publication year - 2018
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/ijnm.ijnm_77_18
Subject(s) - medicine , positron emission tomography , positron emission tomography computed tomography , nuclear medicine , breast cancer , computed tomography , positron emission , fluorodeoxyglucose , tomography , radiology , computed tomography laser mammography , cancer , preclinical imaging , biology , microbiology and biotechnology , in vivo
18 F-Fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) is now recognized as a staging investigation for locally advanced breast cancer. This retrospective review of data was performed to correlate the maximum standardized uptake value (SUV max ) of the primary tumor with the molecular subtype of breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here